Search

Your search keyword '"Capobianchi, Maria R."' showing total 484 results

Search Constraints

Start Over You searched for: Author "Capobianchi, Maria R." Remove constraint Author: "Capobianchi, Maria R."
484 results on '"Capobianchi, Maria R."'

Search Results

1. Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape Mutations

4. Liver transplant recipients and prioritization of anti‐HCV therapy: an Italian cohort analysis

5. Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19)

8. A collaborative study to establish the 1st WHO International Standard for human cytomegalovirus for nucleic acid amplification technology

11. Molecular Characterization of Autochthonous Chikungunya Cluster in Latium Region, Italy

13. Measles cases during Ebola outbreak, West Africa, 2013-2106

15. Potential risks of Oropouche virus importation into Europe.

22. Differential Dynamics of SARS-CoV-2 Binding and Functional Antibodies upon BNT162b2 Vaccine: A 6-Month Follow-Up

23. GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adults

24. Hepatitis E virus genotype 4 outbreak, Italy, 2011

25. Phylogenetic analysis of West Nile virus isolates, Italy, 2008-2009

26. Alkhurma hemorrhagic fever in travelers returning from Egypt, 2010

27. Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failure

28. Late Relapse and Reinfection in HCV Patients Treated with Direct-Acting Antiviral (DAA) Drugs

29. Pharmacokinetics of remdesivir and GS-441524 in two critically ill patients who recovered from COVID-19

30. An inflammatory profile correlates with decreased frequency of cytotoxic cells in COVID-19

34. GRAd-COV2, a gorilla adenovirus based candidate vaccine against COVID-19, is safe and immunogenic in young and older adults

36. Underevaluation of HIV-1 plasma viral load by a commercially available assay in a cluster of patients infected with HIV-1 A/G circulating recombinant form (CRF02)

39. Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape Mutations

41. Synthetic antibodies neutralize SARS-CoV-2 infection of mammalian cells

42. An Inflammatory Profile Correlates With Decreased Frequency of Cytotoxic Cells in Coronavirus Disease 2019

Catalog

Books, media, physical & digital resources